United States · FDA National Drug Code directory

allergy relief D12

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0363-4923_7b2562f7-d202-464a-a703-65d77a49031a
Product NDC
0363-4923
Form
TABLET, FILM COATED, EXTENDED RELEASE
Composition / generic term
Cetirizine hydrochloride, Pseudoephedrine hydrochloride
Labeler
Walgreen Company
Marketing category
ANDA
Marketing start / end (source format)
20211020
Source listing expiry
20271231

Source-listed ingredients

  • CETIRIZINE HYDROCHLORIDE — 5 mg/1
  • PSEUDOEPHEDRINE HYDROCHLORIDE — 120 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 12 BLISTER PACK in 1 CARTON (0363-4923-53) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 0363-4923-53
  • 24 BLISTER PACK in 1 CARTON (0363-4923-62) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 0363-4923-62

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →